Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study

Objective The association between ulcerative colitis (UC) and colorectal cancer (CRC) is widely accepted, although attenuated risk has been reported in recent years. Colonoscopic surveillance is recommended with intervals based on established clinical risk factors. Nevertheless, a significant number...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomm Bernklev, Pasquale Klepp, Stephan Brackmann, Milada Cvancarova, Marte Lie Hoivik, Øistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Ole Hoie, Iril Kempski-Monstad, Inger Camilla Solberg, Njaal Stray, Jorgen Jahnsen, Bjorn Moum
Format: Article
Language:English
Published: BMJ Publishing Group 2020-12-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/7/1/e000361.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846122924015091712
author Tomm Bernklev
Pasquale Klepp
Stephan Brackmann
Milada Cvancarova
Marte Lie Hoivik
Øistein Hovde
Magne Henriksen
Gert Huppertz-Hauss
Ole Hoie
Iril Kempski-Monstad
Inger Camilla Solberg
Njaal Stray
Jorgen Jahnsen
Bjorn Moum
author_facet Tomm Bernklev
Pasquale Klepp
Stephan Brackmann
Milada Cvancarova
Marte Lie Hoivik
Øistein Hovde
Magne Henriksen
Gert Huppertz-Hauss
Ole Hoie
Iril Kempski-Monstad
Inger Camilla Solberg
Njaal Stray
Jorgen Jahnsen
Bjorn Moum
author_sort Tomm Bernklev
collection DOAJ
description Objective The association between ulcerative colitis (UC) and colorectal cancer (CRC) is widely accepted, although attenuated risk has been reported in recent years. Colonoscopic surveillance is recommended with intervals based on established clinical risk factors. Nevertheless, a significant number of patients develop interval cancers, indicating the need of improved individualised assessment. In the present study, we evaluated clinical risk factors associated with CRC during a prescheduled follow-up 20 years after diagnosis, the IBSEN study.Design A population-based inception cohort of patients diagnosed with inflammatory bowel disease from 1 January 1990 until 31 December 1993, prospectively followed at 1, 5, 10 and 20 years after diagnosis. A total of 517 patients with UC were included; 264 (51 %) men; median age at inclusion 37.4 years (4–88).Results The overall incidence of CRC was 1.6% (8/517) at a 20-year follow-up. The total lifetime risk of CRC prior to or after UC diagnosis was 2.3%. (12/517). Patients older than 70 years at diagnosis had a 15-fold higher risk of CRC compared with those diagnosed when younger than 40 years, with HR 15.68 (95% CI: 1.31 to 187.92). Neither sex, first-degree relative with CRC, extent of colitis nor primary sclerosing cholangitis affected the risk of CRC.Conclusion The risk of CRC in UC was low and comparable with the risk of CRC in the background population of Norway.
format Article
id doaj-art-b1a50baed0c94cc7b63566680dfc95f3
institution Kabale University
issn 2054-4774
language English
publishDate 2020-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-b1a50baed0c94cc7b63566680dfc95f32024-12-14T12:05:09ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742020-12-017110.1136/bmjgast-2019-000361Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN studyTomm Bernklev0Pasquale Klepp1Stephan Brackmann2Milada Cvancarova3Marte Lie Hoivik4Øistein Hovde5Magne Henriksen6Gert Huppertz-Hauss7Ole Hoie8Iril Kempski-Monstad9Inger Camilla Solberg10Njaal Stray11Jorgen Jahnsen12Bjorn Moum13R&D Department, Vestfold Hospital Trust, Tønsberg, Vestfold, NorwayUnger-Vetlesen Institute, Lovisenberg Diakonale Hospital, Oslo, NorwayDepartment of Gastroenterology, Akershus University Hospital, Lorenskog, NorwayDepartment of Gastroenterology, Oslo University Hospital, Oslo, NorwayDepartment of Gastroenterology, Oslo University Hospital, Oslo, NorwayFaculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, NorwayDepartment of Gastroenterology, Østfold Hospital Trust, Gralum, Kalnes, NorwayDepartment of Gastroenterology, Telemark Hospital, Ulefossveien, Skien, NorwayDepartment of Internal Medicine, Sørlandet Hospital, Sykehusveien, Arendal, NorwayDepartment of Internal Medicine, Lovisenberg Diakonale Hospital, Oslo, NorwayDepartment of Gastroenterology, Oslo University Hospital, Oslo, NorwayDepartment of Internal Medicine, Diakonhjemmet Hospital, Oslo, Norway2 Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayDepartment of Gastroenterology, Oslo University Hospital, Oslo, NorwayObjective The association between ulcerative colitis (UC) and colorectal cancer (CRC) is widely accepted, although attenuated risk has been reported in recent years. Colonoscopic surveillance is recommended with intervals based on established clinical risk factors. Nevertheless, a significant number of patients develop interval cancers, indicating the need of improved individualised assessment. In the present study, we evaluated clinical risk factors associated with CRC during a prescheduled follow-up 20 years after diagnosis, the IBSEN study.Design A population-based inception cohort of patients diagnosed with inflammatory bowel disease from 1 January 1990 until 31 December 1993, prospectively followed at 1, 5, 10 and 20 years after diagnosis. A total of 517 patients with UC were included; 264 (51 %) men; median age at inclusion 37.4 years (4–88).Results The overall incidence of CRC was 1.6% (8/517) at a 20-year follow-up. The total lifetime risk of CRC prior to or after UC diagnosis was 2.3%. (12/517). Patients older than 70 years at diagnosis had a 15-fold higher risk of CRC compared with those diagnosed when younger than 40 years, with HR 15.68 (95% CI: 1.31 to 187.92). Neither sex, first-degree relative with CRC, extent of colitis nor primary sclerosing cholangitis affected the risk of CRC.Conclusion The risk of CRC in UC was low and comparable with the risk of CRC in the background population of Norway.https://bmjopengastro.bmj.com/content/7/1/e000361.full
spellingShingle Tomm Bernklev
Pasquale Klepp
Stephan Brackmann
Milada Cvancarova
Marte Lie Hoivik
Øistein Hovde
Magne Henriksen
Gert Huppertz-Hauss
Ole Hoie
Iril Kempski-Monstad
Inger Camilla Solberg
Njaal Stray
Jorgen Jahnsen
Bjorn Moum
Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
BMJ Open Gastroenterology
title Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
title_full Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
title_fullStr Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
title_full_unstemmed Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
title_short Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
title_sort risk of colorectal cancer in a population based study 20 years after diagnosis of ulcerative colitis results from the ibsen study
url https://bmjopengastro.bmj.com/content/7/1/e000361.full
work_keys_str_mv AT tommbernklev riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT pasqualeklepp riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT stephanbrackmann riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT miladacvancarova riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT marteliehoivik riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT øisteinhovde riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT magnehenriksen riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT gerthuppertzhauss riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT olehoie riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT irilkempskimonstad riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT ingercamillasolberg riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT njaalstray riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT jorgenjahnsen riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy
AT bjornmoum riskofcolorectalcancerinapopulationbasedstudy20yearsafterdiagnosisofulcerativecolitisresultsfromtheibsenstudy